Healthcare Global Valuation

HCG Stock   511.80  2.85  0.55%   
At this time, the firm appears to be overvalued. Healthcare Global retains a regular Real Value of USD425.44 per share. The prevalent price of the firm is USD511.8. Our model calculates the value of Healthcare Global from evaluating the firm fundamentals such as return on equity of 0.0693, and Return On Asset of 0.0404 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book
8.325
Enterprise Value
84.4 B
Enterprise Value Ebitda
21.6583
Price Sales
3.5106
Trailing PE
126.6832
Overvalued
Today
511.80
Please note that Healthcare Global's price fluctuation is very steady at this time. Calculation of the real value of Healthcare Global is based on 3 months time horizon. Increasing Healthcare Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Healthcare stock is determined by what a typical buyer is willing to pay for full or partial control of Healthcare Global Enterprises. Since Healthcare Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Healthcare Stock. However, Healthcare Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  511.8 Real  425.44 Hype  511.09 Naive  494.91
The real value of Healthcare Stock, also known as its intrinsic value, is the underlying worth of Healthcare Global Company, which is reflected in its stock price. It is based on Healthcare Global's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Healthcare Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
423.15
Downside
425.44
Real Value
562.98
Upside
Estimating the potential upside or downside of Healthcare Global Enterprises helps investors to forecast how Healthcare stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healthcare Global more accurately as focusing exclusively on Healthcare Global's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.100.210.31
Details
Hype
Prediction
LowEstimatedHigh
508.80511.09513.38
Details
Naive
Forecast
LowNext ValueHigh
492.62494.91497.20
Details

Healthcare Global Cash

3.29 Billion

Healthcare Global Total Value Analysis

Healthcare Global Enterprises is currently forecasted to have takeover price of 84.36 B with market capitalization of 71.74 B, debt of 12.74 B, and cash on hands of 773.02 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Healthcare Global fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
84.36 B
71.74 B
12.74 B
773.02 M

Healthcare Global Investor Information

About 72.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Healthcare Global Enterprises is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities3.4 B3.3 B
Sufficiently Up
Slightly volatile

Healthcare Global Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Healthcare Global has an asset utilization ratio of 69.8 percent. This indicates that the Company is making USD0.7 for each dollar of assets. An increasing asset utilization means that Healthcare Global Enterprises is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Healthcare Global Ownership Allocation

Healthcare Global Enterprises has a total of 139.4 Million outstanding shares. Healthcare Global retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.54 (percent) of Healthcare Global outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Healthcare Global Profitability Analysis

The company reported the revenue of 18.9 B. Net Income was 677.29 M with profit before overhead, payroll, taxes, and interest of 10.98 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Healthcare Global's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Healthcare Global and how it compares across the competition.

About Healthcare Global Valuation

The stock valuation mechanism determines Healthcare Global's current worth on a weekly basis. Our valuation model uses a comparative analysis of Healthcare Global. We calculate exposure to Healthcare Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Healthcare Global's related companies.
Last ReportedProjected for Next Year
Gross Profit11.3 B11.8 B

Complementary Tools for Healthcare Stock analysis

When running Healthcare Global's price analysis, check to measure Healthcare Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthcare Global is operating at the current time. Most of Healthcare Global's value examination focuses on studying past and present price action to predict the probability of Healthcare Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthcare Global's price. Additionally, you may evaluate how the addition of Healthcare Global to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data